These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4201168)

  • 21. A unique IgG myeloma immunoglobulin--molecular weight and other properties.
    Bobrzecka K; Konieczny L; Rybarska J; Bogdal J; Urasiński I
    Biochim Biophys Acta; 1973 Feb; 295(2):564-75. PubMed ID: 4633530
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of subclass-related F(ab)2, Fab-c and Fch fragments obtainined by short papain digestion of human IgG myeloma proteins.
    Michaelsen TE; Natvig JB
    Scand J Immunol; 1973; 2(3):299-312. PubMed ID: 4203731
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biclonal myeloma (IgG and IgA)].
    González Barón M; Martínez Fernández A; Durán A; Montero JM; Ordoñez A; Gasalla R
    Rev Clin Esp; 1973 Feb; 128(4):345-8. PubMed ID: 4700587
    [No Abstract]   [Full Text] [Related]  

  • 24. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 25. Double spike in myeloma serum due to retention of light chains.
    Zinneman HH; Seal US
    Arch Intern Med; 1969 Jul; 124(1):77-80. PubMed ID: 4978219
    [No Abstract]   [Full Text] [Related]  

  • 26. Release of a low molecular weight Fc-like fragment on reduction of water-insoluble IgG myeloma proteins.
    Morris GG; Osterland CK; Chaplin H
    Vox Sang; 1974; 27(4):273-86. PubMed ID: 4278247
    [No Abstract]   [Full Text] [Related]  

  • 27. IgA pyroglobulin, hyperviscosity syndrome and coagulation abnormality in a patient with multiple myeloma.
    Sugai S
    Blood; 1972 Feb; 39(2):224-37. PubMed ID: 5009027
    [No Abstract]   [Full Text] [Related]  

  • 28. SOME PROPERTIES OF BETA-2A-MYELOMA PROTEINS.
    LEVIN WC; RITZMANN SE; SEEUWEN JP; NANNINGA L
    Clin Chim Acta; 1964 Jul; 10():12-20. PubMed ID: 14216185
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.
    Kyle RA; Finkelstein S; Elveback LR; Kurland LT
    Blood; 1972 Nov; 40(5):719-24. PubMed ID: 4627911
    [No Abstract]   [Full Text] [Related]  

  • 30. [D-myeloma (observation of 8 cases)].
    Mokeeva RA; Verevkin IN; Piasik MV; Grigorian GD; Rybakova ME
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):41-5. PubMed ID: 6795618
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple myeloma protein with three light chains.
    Sun T; Erichson RB; Lien YY; Wu CH
    Clin Chem; 1982 May; 28(5):1227-30. PubMed ID: 6804124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IgG subclass distribution in 659 myeloma sera.
    Skvaril F; Morell A; Barandun S
    Vox Sang; 1972 Dec; 23(6):546-51. PubMed ID: 4632944
    [No Abstract]   [Full Text] [Related]  

  • 33. Immuno- and physicochemical studies of an IgA-IgG mixed cryoglobulin.
    Takeda K; Okumura H; Hirose S; Muranaka M
    Int Arch Allergy Appl Immunol; 1974; 46(1):38-52. PubMed ID: 4205310
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein.
    Lindsley H; Teller D; Noonan B; Peterson M; Mannik M
    Am J Med; 1973 May; 54(5):682-8. PubMed ID: 4701949
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation of IgG3 from normal human sera and from a patient with multiple myeloma by using protein A-sepharose 4B.
    Hjelm H
    Scand J Immunol; 1975; 4(7):633-40. PubMed ID: 812176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).
    Chen BL; Poljak RJ
    Biochemistry; 1974 Mar; 13(6):1295-302. PubMed ID: 4814727
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 38. Laboratory monitoring of myeloma proteins.
    Kyle RA; Garton JP
    Semin Oncol; 1986 Sep; 13(3):310-7. PubMed ID: 3094148
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of three feline paraproteins.
    Kehoe JM; Hurvitz AI; Capra JD
    J Immunol; 1972 Sep; 109(3):511-6. PubMed ID: 4115543
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological studies in multiple myeloma.
    Aikat BK; Sehgal S; Datta U
    Indian J Med Res; 1971 Jul; 59(7):1062-71. PubMed ID: 5161551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.